IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The GotStocks Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels.

The GotStocks Podcast puts the small-cap sector in the limelight with in-depth interviews featuring executives responsible for guiding gems that could be on the cusp of huge moves. The latest episode features Joel Fruendt, President and CEO of SenesTech Inc. (NASDAQ: SNES), the leader in fertility control to manage animal pest populations.

To begin the interview, Fruendt provided an introduction to SenesTech® and its business model.

“SenesTech is a biotech and life sciences company. Our mission is to improve public health by managing animal pest populations through fertility control, particularly one of the world's oldest issues – rodent control,” Fruendt said. “Right now, we have labels for rats and mice, and we attack the problem at its root cause – reproduction. In essence, what we're doing is rodent birth control. Many cities and other government agencies are trying to control rodent problems by poisoning and killing and trapping and all those things. We're a little bit different in that respect.”

“I'll start out with this fact that usually leaves people with their jaws dropping: two rats, in one year, can become 15,000. That is really the basis for our product. You cannot poison, trap or drown rats fast enough without addressing the reproductive rate, and that is really why our product is in the news a lot right now and why we're getting such success out in the marketplace.”

“SenesTech started as a research company looking at compounds that would mimic menopause. The company came across something that was developed into a product called ContraPest®. It’s a patented technology that really reduces or eliminates fertility in both females and males. It's proven itself out in the field, and we introduced some different delivery systems in order to be more focused on how rats are in the marketplace, whether they're in their burrows or they're roof rats. We have very loyal customers that love the product, so it's an attractive solution for them.”

Join IBN’s Carmel Fisher and Joel Fruendt, President and CEO of SenesTech Inc., to learn more about the company’s newest offering, Evolve™, a soft bait product offering similar efficacy to ContraPest with a number of competitive advantages.

To hear the episode and subscribe for future podcasts, visit https://podcast.gotstocks.net

The latest installment of The GotStocks Podcast continues to reinforce IBN’s commitment to the expansion of its robust network of brands, client partners, followers, and the growing IBN Podcast Series. For more than 18 years, IBN has leveraged this commitment to provide unparalleled distribution and corporate messaging solutions to 500+ public and private companies.

To learn more about IBN’s achievements and milestones via a visual timeline, visit: https://IBN.fm/TimeLine

Nextech3D.AI (OTCQX:NEXCF) (CSE:NTAR) (FSE:1SS) recently announced that it is launching the next era of GPT AI 3D product solutions of proprietary Artificial Intelligence (AI) algorithms. The initiative will be led by former Microsoft Executive Hareesh Achi, who is Nextech3D.ai’s current Head of Product Operations.

The Company believes that the AI opportunity is in the early stages, and that the shift from 2D to 3D modeling for e-commerce is part of a major multi-decade transformation that is being led by AI. The Company is working on annual enterprise licensing deals for its suite of GPT AI solutions for 3D models and 3D maps.

“I am thrilled about the exciting developments taking place at Nextech, where we are harnessing the power of our advanced AI technology stack to create innovative 3D GPT tools that significantly enhance productivity and make it easy to create 3D environments that complement the growth of augmented reality and virtual reality marketplaces,” Achi stated in the news release. “In addition to this, we are dedicated to sharing our extensive 3D expertise with both clients and partners alike. It brings me great joy to anticipate the diverse array of 3D creators who will be able to leverage our cutting-edge technology, empowering them to craft extraordinary 3D experiences.”

To read the original press release, visit: https://nnw.fm/H4iQF

Please see full terms of use and disclaimers on the IBN website applicable to all content provided by IBN, wherever published or re-published: https://IBN.fm/Disclaimer

Gage Cannabis is a premium adult-use cannabis retailer in Ayer, Massachusetts with a mission to provide customers with a diverse selection of the best cannabis and cannabis-infused products available in Massachusetts.

For more information, visit the company’s website at www.GageCannabisCo.com.

Pac Roots (CSE: PACR) is focused on delivering the finest genetics to Canadians. Preserving the excellence of its elite strains while introducing the highest quality of new strains to the public is the company’s passion. The foundation, based on genetic variation and stability, drives the decision making for Pac Roots Cannabis Corp.’s business.

GoldHaven Resources (CSE: GOH) (OTCQB: ATUMF) is a Canadian junior exploration company active in the Maricunga Gold Belt of Northern Chile. The Maricunga measures 150 km north-south and 30 km. east-west and is host to discoveries in the last 10 years of 100M oz. gold; 450M oz. silver and 1.3 billion lbs. copper. The company has agreements in place to acquire seven projects with extensive surface study. GoldHaven has identified four of its seven properties as “high-priority targets,” three of which the company plans to drill commencing January 2021. These priority targets were designated as such due, first, to the analytical work that has been completed on all the properties and, second, to their relative locations in respect to existing deposits. One such existing project is Coya, located approximately 16 km. northeast of the La Coipa mine, where Kinross extracted over 6.2 million oz. Other existing projects include Rio Loa and Alicia, which are respectively 25 km. and 30 km. distance from GoldHaven’s Salares Norte deposit with a discovery of 5M oz. gold, 450M oz. silver and 1.3B lbs. copper.

Predictive Oncology (NASDAQ: POAI) operates through three segments (domestic, international and other), which contain four subsidiaries: Helomics, TumorGenesis, Skyline Medical and Soluble Biotech.

Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. TumorGenesis Inc. specializes in media that help cancer cells grow and retain their DNA/RNA and proteomic signatures, providing researchers with a tool to expand and study cancer cell types found in tumors of the blood and organ systems of all mammals, including humans. Skyline Medical markets its patented and FDA cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. Soluble Biotech is a provider of soluble and stable formulations for proteins including vaccines, antibodies, large and small proteins and protein complexes.

After offering some brief insight into the operations of Skyline Medical, Schwartz turned his attention toward TumorGenesis. “TumorGenesis is an interesting company. The whole purpose of it was to develop a lab media to replace rats and mice in the scientific industries and in the testing of tumors,” he stated in the interview. “They have developed the first one, which is ovarian cancer, and the results of this are that this media, which, as I said, replicates the body, fools the tumor into thinking it’s still in the body. Its reactions are very, very similar to what it would have done had it been in the body. Now, the next step is to get it positioned to manufacturers and getting the kits out so people can use it. That’s coming along handsomely. It’ll take a little time to get all this put in place, but the optimism is there, and the results are wonderful. We’re very excited.”

Founded in 2012, The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER) is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88(R), is a leading premier alkaline water brand available in bulk and single-serve sizes along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88 delivers perfect 8.8 pH-balanced alkaline drinking water with trace minerals and electrolytes and boasts its trademarked label: Clean Beverage. Quickly being recognized as a growing lifestyle brand, Alkaline88 launched A88 Infused(TM) in 2019 to meet consumer demand for flavor-infused products. A88 Infused flavored water is available in seven unique all-natural flavors with new flavors coming soon. Additionally, in 2020, the company launched A88 Infused Beverage Division Inc., which includes the company’s CBD water and flavor-infused water. For the company’s topical and ingestible offerings, A88 Infused Products includes both the company’s lab-tested, full-spectrum hemp salves, balms, lotions, essential oils and bath salts, along with broad-spectrum hemp beverage shots, powder packs, oil tinctures, capsules and gummies.

Cybin Corp. is a mushroom life-science company advancing psychedelic and nutraceutical-based products. The company expects to launch psilocybin-based products in jurisdictions where the substance is not prohibited. Simultaneously, the company is structuring and supporting clinical studies across North America and other regions through strategic academic and institutional partnerships.

ISW Holdings (OTC: ISWH), based in Nevada, is a diversified portfolio company comprised of essential business lines that serve consumer product demands. Its expertise lies in strategic brand development, early growth facilitation, as well as brand identity through the company’s proprietary procurement process. Together with its partners, ISW Holdings seeks to provide a structure that meets large scalability demands as well as anticipated marketplace needs. It is able to meet these needs through a variety of strategic, innovative processes. ISWH is creating and managing brands across a spectrum of disruptive industries. It maneuvers its proprietary companies through critical stages of market development, which include conceptualization, go-to-market strategies, engineering, product integration, and distribution efficiency. The company has also partnered with a well-known software development and consulting company, Bengala Technologies LLC, which is developing significant enhancements in the supply chain management space; the partnership has a vitally needed patent pending.

National Storm Recovery (OTC: NSRI), through its subsidiaries, provides tree services, debris hauling and removal, biomass recycling, mulch manufacturing, packaging and sales. The company was established with the objective of providing a solution for the treatment and handling of tree debris that has historically been disposed of in landfills, creating an environmental burden and pressure on disposal sites around the nation. The company and its Sustainable Green Team’s solutions are founded in sustainability, based on vertically integrated operations that begin with collecting tree debris through the company’s tree services division and collection sites, and then, through the company’s processing division, recycling and using that tree debris as a feedstock that is manufactured into a variety of organic, attractive, next-generation mulch products that are packaged and sold to landscapers, installers and garden centers. The company plans to expand its operations through a combination of organic growth and strategic acquisitions that are both accretive to earnings and are positioned for rapid growth from the resulting synergistic opportunities identified. The company’s customers include governmental, residential and commercial clients.

The Movie Studio (OTC: MVES) operates as a vertically integrated motion-picture production and distribution company. The company acquires, develops, produces and distributes independent motion-picture content for worldwide consumption via theatrical release, video on demand, foreign sales and various media devices. MVES is disrupting traditional media-content delivery systems with its digital business model of motion picture distribution. The company was formerly known as Destination Television Inc. and changed its name to The Movie Studio Inc. in November 2012. The Movie Studio Inc. was founded in 1961 and is headquartered in Fort Lauderdale, Florida.

Bullfrog Gold (CSE: BFG) (OTCQB: BFGC) (FSE: 11B) is a Delaware corporation that controls the commanding land and mineral positions in the Bullfrog Mine area. In this area, Barrick produced 2.3 million ounces of gold through conventional milling beginning in 1989 and ending in 1999.

Vision Marine Technologies Inc. (NASDAQ: VMAR) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 60+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community.  

To view the full publication, “The Electrifying Rise of Electric Boats,” please visit: https://nnw.fm/XziTP   

The raucous rumble of combustion engines is fading, systematically replaced by the high-performance hum of electric propulsion that’s transforming every aspect of transport. Electric cars have moved mainstream with both automakers and upstarts offering multiple mobility options. Now another market is being disrupted, as sleek electric boats glide across the water leaving nothing but a whisper of ripples in their wake.    

This surge in electrification isn't just about a clean and green conscience; it's about performance, convenience and a technological transition in mobility that may be as profound as the shift from the horse to the horseless carriage. The producer of the world’s most powerful and most technically advanced electric outboard motor on the market today, Vision Marine Technologies Inc. (NASDAQ: VMAR) (Profile), is a recognized global leader, innovator and disruptive force in the electrification of recreational boating.   

About Vision Marine Technologies Inc.  

Vision Marine Technologies is a leader in the marine industry’s shift to electric propulsion and is at the vanguard of this transformation. The company’s pioneering E-Motion(TM) outboard powertrain system represents a significant leap in marine technology. As a champion of ecofriendly electric powerboats, the company is not just participating in the industry’s evolution, it is driving it. The company’s Flagship E-Motion(TM) 180E electric marine powertrain is the first fully electric, purpose-built outboard powertrain system that combines an advanced battery pack, inverter and high-efficiency motor with proprietary union assembly between the transmission and the electric-motor design utilizing extensive control software. VMAR’s E-Motion and related technologies used in this powertrain system are uniquely designed to improve the efficiency of the outboard powertrain and, as a result, enhance both range and performance. Vision Marine continues to design, innovate, manufacture and sell handcrafted, environmentally friendly, electric recreational boats to customers. The design and technology applied to its boats result in far greater enhanced performance in general as well as higher speeds, longer range and a smoother ride than a traditional internal combustion engine (“ICE”) motorboat.   

For more information about the company, please visit www.VisionMarineTechnologies.com. 

Exro Technologies (CSE: XRO) (OTCQB: EXROF) is a Clean Tech company that has developed a new class of control technology for electric powertrains. Exro’s advanced motor control technology, its “Coil Driver,” expands the capabilities of electric motors and powertrains. The Coil Driver enables two separate torque profiles within a given motor. The first is calibrated for low speed and high torque, while the second provides expanded operation at high speed. The ability to change configuration allows efficiency optimization for each operating mode, resulting in overall reductions in energy consumption. The controller automatically and seamlessly selects the appropriate configuration in real-time so that torque demand and efficiency are optimized.

National Storm Recovery (OTC: NSRI), through its subsidiaries, provides tree services, debris hauling and removal, biomass recycling, mulch manufacturing, packaging and sales. The company was established with the objective of providing a solution for the treatment and handling of tree debris that has historically been disposed of in landfills, creating an environmental burden and pressure on disposal sites around the nation. The company and its Sustainable Green Team’s solutions are founded in sustainability, based on vertically integrated operations that begin with collecting of tree debris through its tree services division and collection sites, then through processing, recycling and using that tree debris as feedstock that is manufactured into a variety of organic, attractive, next-generation mulch products that are packaged and sold to landscapers, installers and garden centers. The company plans to expand its operations through a combination of organic-growth and strategic acquisitions that are both accretive to earnings and positioned for rapid growth from the resulting synergistic opportunities identified. NSRI serves governmental, residential and commercial customers.

Predictive Oncology (NASDAQ: POAI) operates through three segments (domestic, international and other) that contain four subsidiaries; Helomics, TumorGenesis, Skyline Medical and Skyline Europe. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomics’ CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based road map for therapy. In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor(TM), patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary bioinformatics platform to provide a tailored solution to its clients’ specific needs. Predictive Oncology’s TumorGenesis subsidiary is developing a new rapid approach to growing tumors in the laboratory, which essentially “fools” cancer cells into thinking they are still growing inside a patient. Its proprietary Oncology Discovery Technology Platform Kits will assist researchers and clinicians to identify which cancer cells bind to specific biomarkers. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms, which isolate and help categorize an individual patient’s heterogeneous tumor samples to enable the development of patient-specific treatment options. Helomics and TumorGenesis are focused on ovarian cancer. Predictive Oncology’s Skyline Medical division markets its patented and FDA-cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. The company has achieved sales in five of the seven continents through both direct sales and distributor partners.

Champignon Brands (CSE: SHRM) has positioned itself to rapidly become a global force as a vertically integrated producer of artisanal medicinal mushrooms and associated products. The Champignon team is focused on enhancing the health and wellness of millions of consumers who can benefit from its premium suite of organic, sustainable and non-GMO mushroom and mushroom-infused formulations.

Bolt Metals Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) is a Canadian‐based exploration company focused on the acquisition and development of production grade cobalt and nickel deposits, key raw material inputs for the growing lithium‐ion battery industry.

SRAX (NASDAQ: SRAX) is a digital-marketing and consumer-data-management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and the characteristics of those consumers across marketing channels. Monetizing its data sets, SRAX is growing multiple, recurring revenue streams through various platforms. Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby offering everyone in the internet ecosystem choice, transparency and compensation. SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor-relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.

Plus Products (CSE: PLUS) (OTCQX: PLPRF) is a hemp and cannabis food company focused on using nature to bring balance to consumers’ lives. PLUS’s mission is to make cannabis safe and approachable, beginning with high-quality products that deliver consistent consumer experiences. PLUS is headquartered in San Mateo, California, and has 80 employees. For more information, visit the company’s website at www.PlusProductsInc.com.

MCTC Holdings Inc. (MCTC), doing business as Cannabis Global Inc., is focused on delivering long-term shareholder growth and results. The company invests with confidence and determination to be the forefront of the cannabis and CBD revolution.

Trxade Group (NASDAQ: MEDS) (OTCQB: TRXD) is an integrated drug procurement, delivery and healthcare platform that enables price transparency and increased profit margins to healthcare buyers and sellers of pharmaceuticals, accessories and services. Founded in 2010, Trxade Group is comprised of three synergistic operating platforms; the Trxade B2B trading platform with 11,000 registered pharmacies, licensed virtual Wholesale and Mail Order Pharmacy capabilities including DelivMeds, as well as the newly acquired assets of Bonum Health.

Sigma Labs (NASDAQ: SGLB) is an emerging provider of quality-assurance software to the commercial 3D-printing industry under the PrintRite3D brand. Founded in 2010, Sigma is a software company that specializes in the development and commercialization of real-time, computer-aided inspection (“CAI”) solutions known as PrintRite3D for 3D, advanced-manufacturing technologies. Sigma Labs’ advanced computer-aided software product revolutionizes commercial additive manufacturing, enabling nondestructive quality assurance mid-production, uniquely allowing errors to be corrected in real time.

Alarum Technologies Ltd. (Nasdaq, TASE: ALAR) (“Alarum” or the “Company”), a global provider of internet access and web data collection solutions, today announces that it has been featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio news release covers the recent announcement that the Company anticipates reporting record revenue and operating cashflow for the fourth quarter of 2023.

"Alarum is pleased to start 2024 with a strong growth momentum, following the year 2023. We intend to continue supporting our future growth also by expanding our offering in the data collection market and launch new innovative products," Shachar Daniel, Chief Executive Officer of Alarum, stated in the news release.

"The amazing results we achieved in the fourth quarter of 2023 emphasize the positive impact advanced by the strategic business changes we implemented during 2023, which are fostering growth and success. Following our decision to focus on improved profitability and reduce investments in the consumer segment, we anticipated that most of our fourth-quarter revenues will be generated by NetNut. These revenues alone surpass the combined revenue of both NetNut and consumer segments from previous periods," Daniel added. "During the fourth quarter, we also increased our cashflow from operating activities and continued our focus on being a profitable growth company."

To read the original press release, visit: https://www.nnw.fm/W9zk8

Please see full terms of use and disclaimers on the IBN website applicable to all content provided by IBN, wherever published or re-published: https://IBN.fm/Disclaimer

No Borders (OTC: NBDR) is a multifaceted corporation specializing in the acquisition, creation and scaling of commercial and consumer products by utilizing cutting-edge technologies to reduce costs while increasing revenues and shareholder value through technological superiority across its portfolio of assets.

Wonderfilm (OTCQB: WDRFF) (TSX.V: WNDR) is a leading entertainment company with production offices in Los Angeles and corporate offices in Vancouver. The company’s core business is producing market-driven independent feature films and quality television series for multi-platform global exploitation. Wonderfilm is a producer and distributor only for the projects disclosed. The legal ownership of movie productions is held in a special purpose legal entity held at arm’s length to the company to facilitate for the qualification of various levels of domestic and foreign government tax credit incentives that are customary in the film and production business.

Predictive Oncology (NASDAQ: POAI) operates through five segments (Domestic, International, Clinical, CRO and DCHIP), which contain four subsidiaries; Helomics, TumorGenesis, Skyline Medical and Skyline Europe. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomics’ CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy. In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor(TM), patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary bioinformatics platform (D- CHIP) to provide a tailored solution to its clients’ specific needs. Predictive Oncology’s TumorGenesis subsidiary is developing a new rapid approach to growing tumors in the laboratory, which essentially “fools” cancer cells into thinking they are still growing inside a patient. Its proprietary Oncology Discovery Technology Platform kits will assist researchers and clinicians to identify which cancer cells bind to specific biomarkers. Once the biomarkers are identified they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and help categorize an individual patient’s heterogeneous tumor samples to enable the development of patient specific treatment options. Helomics and TumorGenesis are focused on ovarian cancer. Predictive Oncology’s Skyline Medical division markets its patented and FDA cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. The company has achieved sales in five of the seven continents through both direct sales and distributor partners.

OriginClear (OTC: OCLN) addresses the self-reliant water revolution, deploying advanced technologies at the point of use with modular, prefabricated systems that create durable assets and water independence for industry, commerce and agriculture. From its Texas-based factory, OriginClear designs and prefabricates an entire line of plug-n-play containerized Modular Water Systems(TM) that enable water purification, recycling and wastewater management. The company manufactures and distributes these professional-grade, self-reliant units to commercial and industrial properties such as hotels and resorts, real estate housing developments, office buildings, military installations, schools, farms, food and beverage manufacturers, industrial warehouse, oil & gas producers, and medical and pharmaceutical facilities.

LiveWire Ergogenics (OTC: LVVV) specializes in identifying and monetizing current and future trends in the human and veterinarian health and wellness industry. The company is focused on acquiring, managing and licensing specialized “closed loop” turnkey cannabis real estate locations of fully compliant and permitted turnkey facilities to produce cannabis-based products and services in California and the state-wide distribution of these products. This includes verification of zero pesticide products for quality brands via its “7X Pure” Cannabis Verification System, and the development, licensing and distribution of legal, high-quality cannabinoid-based products and services. LiveWire Ergogenics does not sell or distribute products that are in violation of the United States Controlled Substance Act.

CloudCommerce (OTCQB: CLWD) is a leading provider of audience-driven, business-intelligence and digital-marketing solutions. The company’s flagship solution, SWARM, analyzes a robust mix of audience data to help businesses find who to talk to and what to say to when they motivate those businesses to take meaningful action. CloudCommerce does this by applying advanced data science, behavioral science, artificial intelligence and market-research techniques to discover, develop and create custom audiences for any business activity. With applications such as marketing, brand perception, customer-relationship management, human-resources management and operational logistics, SWARM delivers powerful, audience-driven business intelligence to convert opportunities into business success.

Organigram Holdings (TSX: OGI) (NASDAQ: OGI) is a Toronto Stock Exchange and NASDAQ Global Select-listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada. Organigram is focused on producing the highest-quality, indoor-grown cannabis for patients and adult-recreational consumers in Canada, as well as developing international business partnerships to extend the company’s global footprint. Organigram has also developed a portfolio of legal adult-use recreational cannabis brands including the Edison Cannabis Company, Ankr Organics, Trailer Park Buds and Trailblazer. Organigram’s primary facility is located in Moncton, New Brunswick, and the company is regulated by the Cannabis Act and the Cannabis Regulations (Canada).

Xalles Holdings (OTC: XALL) is a holding company that focuses on direct investments in disruptive fintech companies. The company actively seeks acquisition targets in which it can invest and accelerate growth, targeting companies with solid management teams and business models, large total attainable markets (“TAM”), and lucrative exit opportunities. The company places emphasis on leveraging blockchain technologies to provide industry-leading financial reconciliation and auditing solutions, which, over time, will allow for the capture of recurring revenue streams.

SRAX (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels. Monetizing its data sets, SRAX is growing multiple recurring revenue streams through its various platforms. Through the BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data thereby offering everyone in the Internet ecosystem choice, transparency, and compensation. SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury, and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.

Quest Patent Research (OTCQB: QPRC) operates as an intellectual-property, asset-management company delivering financial, strategic and legal resources for IP monetization. It partners with inventors, businesses, corporations and law firms to fully realize the value of IP assets through its suite of value-added services. Quest currently owns, controls or manages more than 115 patents across 11 intellectual property portfolios. Quest trades on the OTCQB Venture Market for early stage and developing U.S. and international companies. Companies are current in their reporting and undergo an annual verification and management certification process.

The GotStocks Podcast’s latest audio production features Charlie Napolitano, Managing Director of DealFlow Events, a premier conference organizer that has hosted hundreds of in-person and virtual events covering a wide array of business and investment topics. 

To begin the interview, Napolitano provided an introduction to DealFlow Events and its upcoming conference schedule. 

“DealFlow focuses on events in the capital markets and we've been focused on that for 21 years with events taking place globally,” Napolitano said. “We’re excited for this next event that we have coming up January 30th through February 1st, which is called The Microcap Conference, in Atlantic City.” 

“Launching [a microcap-focused conference] is something we've been thinking about for quite a while. And we've always been looking for the right time and the right place to host it. And now personally, I go to Atlantic City 5-6 times a year. I'm a big poker guy and when I was down there, it just kind of felt like an untapped resource… As an event company, whose sole purpose is to bring people together into one space, we felt like in the Northeast, we could host something, bring value and bring people to what I think is a great place to have fun.” 

Napolitano then discussed ways that attendees can make the most of their time at DealFlow conferences. 

“I think the first thing that investors can do is take a look at the website or go into MeetMax and start scheduling meetings with companies… They can, right away, schedule time to sit with those people before their calendars fill… Other than just the one-on-one meetings, we have companies presenting as well, and I think that investors would find value from sitting down and hearing from these companies in that sort of setting… The companies that people can expect to have there range from market caps of $30 million to $500 million. We have a couple that are as high as $900 million, and we have some that are in the $10-12 million range, which we found were interesting and good growth opportunities.” 

Join IBN’s Jonathan Keim and The GotStocks Podcast’s latest guest to learn more about the upcoming Microcap Conference, including highlights like the wild west after party and a poker tournament.

ORHub Inc. (OTC: ORHB) is a growth-stage data analytics company on a mission to optimize the business of surgery through lean process improvement. As a Microsoft Silver Partner, ORHub leverages the Azure cloud to help customers unlock the power of data captured in the operating room by surfacing key business indicators into a curated set of dynamic dashboards.

Neutra (OTCQB: NTRR) is an early-stage research and development company committed to bringing modern, healthy-living solutions to a multibillion-dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture — one where consumers are demanding access to products that promote health and stave off potential health dangers. One of the nutraceutical submarkets is the new, thriving, hemp-based CBD market, in which the company intends to participate.

Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), headquartered in Xiamen, China, is a producer, developer and operator of augmented-reality, interactive entertainment games and toys, including interactive educational materials, mobile games and toys with mobile-game features.

Grapefruit Boulevard Investments, a wholly owned subsidiary of Imaging3 (OTCQB: IGNG), holds California permits and licenses to both manufacture and distribute cannabis products. Grapefruit’s cannabis and CBD extraction laboratory and distribution facilities are located in the industry recognized Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, located on the extension of North Canyon Rd., approximately 10 miles north of downtown Palm Springs. Grapefruit obtained its California cannabis licenses in January of 2018 and commenced distribution of cannabis products thereafter. Grapefruit’s vision is to become a seed to sale, fully vertically integrated ethical and compliant cannabis and CBD product company. For more information, visit the company’s website at www.GrapefruitBlvd.com.

A TSX Venture Top 50 Company, Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) is a leading global developer and provider of cellular communications systems for enterprise customers, specializing in connected vehicle products for professional fleets, marketed under the Uniden® Cellular brand. Since developing the world’s first 3G connected vehicle device, Siyata has been a pioneer in the industry, launching the world’s first 4G LTE all-in-one fleet communications device in 2017. Incorporating voice, push-to-talk over cellular, data, and fleet management solutions into a single device, the company aims to become the connected vehicle communications device of choice for commercial vehicles and fleets around the world. Siyata also offers rugged phones for industrial users and signal boosters for homes, buildings, and fleets with poor cell coverage. Siyata’s customers include cellular operators, commercial vehicle technology distributors, and fleets of all sizes in Canada, the U.S., Europe, Australia, and the Middle East.

VPR Brands LP (OTC: VPRB) is a technology company whose assets include issued U.S. and Chinese patents for atomization-related products including technology for medical marijuana vaporizers and electronic cigarette products and components. The company is also engaged in product development for the vapor or vaping market including e-liquids. Vaporizers and electronic cigarettes (also known as e-cigarettes) are devices that deliver nicotine and/or cannabis through atomization or vaping, and without smoke and other chemical constituents typically found in traditional products.

Golden Developing Solutions (OTC: DVLP) is developing an online retail business for cannabidiol (CBD), hemp oil and health/wellness-related products. The company is also developing a high-capacity, high-quality CBD extraction and production facility. In addition, through wholesale and distribution channels, the company offers a broad range of high-quality, price-competitive products, including traditional vitamins; supplements; and CBD-based tinctures, vapes and soft gels, among other products. Merchandise also includes hemp and CBD-related products and additional products focusing on health and lifestyle.

Endonovo Therapeutics Inc. (ENDV) develops, manufactures and distributes evolutionary medical devices focused on the rapid healing of wounds and reduction of pain, edema and inflammation on and in the human body. These wearable, non-invasive medical devices are designed to deliver the company’s proprietary, patent protected Electroceutical™ Therapy targeting inflammation, cardiovascular diseases, chronic kidney disease and central nervous system (“CNS”) disorders.

ORHub (OTC: ORHB) is a growth stage data analytics company on a mission to optimize the business of surgery through lean process improvement. As a Microsoft Silver Partner, ORHub leverages the Azure cloud to help customers unlock the power in their data captured in the OR. Surgical Spotlight(R) helps providers harness that data, identify millions of dollars in opportunities, and get leaders back to their primary focus: improving care, increasing patient access and reducing costs. A first-of-kind team building tool brings all stakeholders together with regular and accessible information. ORHub specializes in business intelligence for the operating room, built by professionals from the operating room.

MustGrow Biologics Corp. (CSE: MGRO) is an agricultural biotech company focused on developing and commercializing its patented natural biologic product that acts as a pesticide, fungicide nematicide and fertilizer. Targeting the fruit, vegetable, turf, ornamentals and cannabis industries, MustGrow has designed a United States EPA-approved organic solution that uses the mustard seed’s natural defense mechanisms to protect plants from pests and diseases. Approximately $9 million has previously been spent on 110 independent tests, validating MustGrow’s remarkably safe and effective granular product. MustGrow’s granular product is EPA-approved across all key U.S. states as a fertilizer and pesticide (currently limited to fertilizer in California) and is designated by Health Canada’s PMRA (Pest Management Regulatory Agency) as a fruit, vegetable, turf and ornamental biopesticide and biofertilizer. In cannabis, MustGrow is currently developing reliable, safe and biological solutions that adhere to Health Canada’s strict regulations. MustGrow is positioning its signature product as an effective pre-plant soil treatment, reducing the chance for any added soil to a greenhouse to bring in pests or diseases. MustGrow expects its biopesticide and biofertilizer will help licensed cannabis producers control the same conditions addressed in fruit and vegetable crops.

The GotStocks Podcast’s latest audio production features Jason Fishman, Co-Founder and CEO of Digital Niche Agency (DNA), a digital marketing service leveraging strategic advertising, content marketing and outreach to effectively raise capital.

To begin the interview, Fishman discussed his background in marketing.

“I started as a growth marketer and launched a firm back in 2014 – DNA, which stands for Digital Niche Agency. I had a long stint in ad tech as part of my growth marketing career before this and wanted to work with startup to mid-market organizations versus just the Fortune 500s that I had been a part of,” Fishman said. “Working with early stage to mid-market organizations, I found a commonality of fundraising: there was always some part of the discussion that included capital raise.”

“I was then introduced to 506(c) Reg D fundraising, which allowed for solicitation. It allowed me to market, use my advertising background, content marketing, or outreach programs that we were doing for clients, and apply them to investors. Business-to-investor marketing became our focus at that point. Suddenly, we were able to address this obstacle that each group was running into. I was able to tap into some different data partnerships that I had in the ad tech world to reach high net worth, high household income audiences across various investor behavior subsets, and we saw success on initial campaigns.”

“I was told about Reg CF, regulation crowdfunding, and that it was not a matter of if but when and how we were going to be able to reach retail, not accredited investors – virtually any adult – for these initiatives. We were brought in for the first campaigns. We had advertising live back in May 2016, day one of Reg CF. To date, I have worked on over 350 equity crowdfunding campaigns alone. We started work on regulation A campaigns later that year, as well… We've also worked with digital asset exchanges. Those have been some of our largest clients to date. Basically, anywhere we're targeting investors and bringing them down marketing funnels, we've been able to shine.”

Join IBN’s Jonathan Keim and The GotStocks Podcast’s latest guest to learn more about the trends driving the digital marketing space forward.

INmune Bio Inc. (NASDAQ: INMB) is a clinical-stage biotechnology company developing therapies targeting the innate immune system to fight disease. INmune Bio is developing three product platforms: two products that reengineer the patient’s innate immune system’s response to cancer and one product to treat neuroinflammation that is currently focused on Alzheimer’s disease. INKmune is a natural killer (“NK”) cell therapeutic that primes the patient’s NK cells to attack minimal residual disease, the remaining cancer cells that are difficult to detect, which often cause relapse. INB03 inhibits myeloid derived suppressor cells (“MDSC”), which often cause resistance to immunotherapy, such as anti-PD-1 checkpoint inhibitors. XPro1595 targets neuroinflammation, which causes microglial activation and neuronal cell death. INmune Bio’s product platforms utilize a precision medicine approach for the treatment of a wide variety of hematologic malignancies, solid tumors and chronic inflammation.

Hemptown USA, headquartered in Central Point, Oregon, is a proven grower of full-spectrum, feminized hemp grown using premium-seed genetics that contain less than 0.3% THC and exceptionally high cannabinoid (CBD) content of up to 20%. The company’s soil-to-oil methodology combines seasoned professionals working in handpicked agricultural microclimates located in Oregon’s famed Emerald Triangle and in Kentucky and Colorado.

Wildflower Brands (CSE: SUN) (OTCQB: WLDFF) is a Vancouver-based company developing and designing brands that focus on plant-based health and wellness products. All of the company’s brands work in synergy, toward becoming a global wellness leader.

Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) intends to provide debt and equity funding in the middle to late stages of a target company’s development or in technologies that are developed and validated by revenues. The present focus of the merchant bank is on medical cannabis, hemp and CBD-related and healthcare-related companies.